Trials / Conditions / Gastric and Gastroesophageal Junction Adenocarcinoma
Gastric and Gastroesophageal Junction Adenocarcinoma
4 registered clinical trials studyying Gastric and Gastroesophageal Junction Adenocarcinoma — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | A Study of AK104/Placebo Plus AK109/Placebo And Paclitaxel in Gastric or Gastroesophageal Junction Adenocarcin NCT06341335 | Akeso | Phase 3 |
| Active Not Recruiting | Pembrolizumab and Trifluridine/Tipiracil With Previously Treated Advanced Gastric Cancer NCT05508737 | Yonsei University | Phase 1 / Phase 2 |
| Completed | Afuresertib +Sintilimab+Chemotherapy in Patients With Selected Solid Tumors That Resistance to Prior Anti-PD-1 NCT05383482 | Laekna Limited | Phase 1 / Phase 2 |
| Terminated | Study of AMG 910 in Subjects With CLDN18.2-Positive Gastric and Gastroesophageal Junction Adenocarcinoma NCT04260191 | Amgen | Phase 1 |